Target This Stock as the Cannabis Shortage Turns to Glut

Alcanna Inc. (TSX:CLIQ) has posted early success with its cannabis retail and supply is poised to ramp up in late 2019.

edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

When Canada legalized recreational cannabis in October 2018, many industry experts expected that supply would be an early issue. This forecast turned out to be correct in the first months of legalization, as demand far outpaced what retailers were able to deliver. The rollout was complicated by varying regulations across the provinces. Ontario, the most populous province in Canada, only recently started allowing legal cannabis retail through brick-and-mortar locations.

Cannabis stocks have encountered volatility in the spring. Sales surprisingly dipped from December 2018 to January 2019, and several of the top producers have reported disappointing earnings. However, the supply shortage is expected to turn in the second half of 2019. In May, the province of Alberta lifted a six-month moratorium on adding new cannabis shops due to the improving supply situation.

Nick Pateras, the vice president for strategy at Lift & Co., recently predicted that we will see “dramatic oversupply in two to three years.”

Alcanna (TSX:CLIQ) is an Edmonton-based private sector retailer of alcoholic beverages in Canada and the United States. It recently partnered with Aurora Cannabis and made a push into the cannabis sector. Shares of Alcanna have climbed 38.4% in 2019 as of close on June 4. However, the stock was still down over 35% from the prior year.

Alcanna released its first-quarter 2019 results on May 9. Sales rose to $149 million compared to $129 million in the prior year. The company reported same-store sales growth of 6.2% in Canada and 6.3% in Alaska. In late May, Alcanna announced an agreement to acquire 28 liquor stores operating under the “Solo Liquor” brand. The acquisition is expected to close later this month.

The big story in the first quarter was Alcanna’s Nova Cannabis division. Sales per store were strong coming out of the gate, and this continued in Q1 2019. However, the company said that its performance was hindered by the cannabis supply shortage. It also mentioned the moratorium on new licences in Alberta. Fortunately for the company, this latter issue has been resolved. At the end of the first quarter, Nova Cannabis received three new licences.

Alcanna has successfully acquired a licence in Ontario and opened its first Nova Cannabis store in Toronto on 499 Queen St. West. A second Nova Cannabis location opened in late May in Sherwood Park. The push into Ontario is a great sign for Alcanna. There were concerns that its link to Aurora would hinder its progress, as Ontario has sought to limit the footprint of large producers in the cannabis retail sector.

The largest producers, including Aurora, are expected to dramatically increase production capacity by the end of 2019. Retailers will be able to look forward to supply no longer being an issue by the middle of 2020.

Alcanna has made promising strides in 2019, but the stock is still reeling from its sharp drop in late 2018. The company is forging ahead with acquisitions and its fledgling cannabis business. Going forward, it will be nice to see more investment in the latter.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »